Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coryandar Gilvary

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|July 7, 2019
The Missing Pieces of Artificial Intelligence in MedicineCoryandar Gilvary, Neel Madhukar, Jamal Elkhader, et al.
Cancer Discovery|April 3, 2021
Artificial Intelligence in Cancer Research and Precision MedicineBhavneet Bhinder, Coryandar Gilvary, Neel S Madhukar, et al.
Briefings in Bioinformatics|June 4, 2019
Graph convolutional networks for computational drug development and discoveryMengying Sun, Sendong Zhao, Coryandar Gilvary, et al.
Plos Computational Biology|August 9, 2020
A machine learning and network framework to discover new indications for small moleculesCoryandar Gilvary, Jamal Elkhader, Neel Madhukar, et al.
The Journal of Allergy and Clinical Immunology. Global|December 26, 2025
Inflammatory and fibrotic biomarkers in patients with atopic dermatitis treated with cendakimabJie Li, Coryandar Gilvary, Lu Gao, et al.
The British Journal of Dermatology|March 29, 2026
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trialBrett King, Benjamin Ehst, Peter Foley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2018
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 AntagonismVarun V Prabhu, Neel S Madhukar, Coryandar Gilvary, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|July 7, 2019
The Missing Pieces of Artificial Intelligence in MedicineCoryandar Gilvary, Neel Madhukar, Jamal Elkhader, et al.
Cancer Discovery|April 3, 2021
Artificial Intelligence in Cancer Research and Precision MedicineBhavneet Bhinder, Coryandar Gilvary, Neel S Madhukar, et al.
Briefings in Bioinformatics|June 4, 2019
Graph convolutional networks for computational drug development and discoveryMengying Sun, Sendong Zhao, Coryandar Gilvary, et al.
Plos Computational Biology|August 9, 2020
A machine learning and network framework to discover new indications for small moleculesCoryandar Gilvary, Jamal Elkhader, Neel Madhukar, et al.
The Journal of Allergy and Clinical Immunology. Global|December 26, 2025
Inflammatory and fibrotic biomarkers in patients with atopic dermatitis treated with cendakimabJie Li, Coryandar Gilvary, Lu Gao, et al.
The British Journal of Dermatology|March 29, 2026
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trialBrett King, Benjamin Ehst, Peter Foley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2018
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 AntagonismVarun V Prabhu, Neel S Madhukar, Coryandar Gilvary, et al.
Pageof 1